Ro-Kaye Simmonds
Chicago, ILNPI 1205481850
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,459 of the $4,384 with a category attached, or 78.9%. It is spread thinly across 27 manufacturers, the largest accounting for just 15.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,952, 4.0 times the $490 reported in 2022.
Across 94 payments — averaging $46.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Philips North America LLC$693
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$460
- Abiomed$444
- Edwards Lifesciences$382
- Boston Scientific$338
- Novartis$258
- plus $2K from 21 others
What the payments were for
- Travel & lodging$69316%
- Food & beverage$3,45979%
- Education$2325%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Philips North America LLC | 3 | $693 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 9 | $460 |
| Abiomed | 6 | $444 |
| Edwards Lifesciences | 3 | $382 |
| Boston Scientific | 7 | $338 |
| Novartis | 12 | $258 |
| Pfizer | 10 | $229 |
| Medtronic | 3 | $183 |
| Penumbra, Inc. | 2 | $175 |
| Stryker | 1 | $157 |
| Shockwave Medical, Inc | 11 | $154 |
| Cardiovascular Systems Inc. | 1 | $142 |
| Sanofi-aventis U.S. LLC | 1 | $118 |
| Teleflex LLC | 1 | $98 |
| E.r. Squibb & Sons, L.L.C. | 4 | $85 |
| Terumo Medical Corporation | 3 | $79 |
| Merck | 3 | $62 |
| Boehringer Ingelheim | 2 | $60 |
| AstraZeneca | 3 | $48 |
| Abbott | 2 | $45 |
| Cardiva Medical, Inc. | 1 | $34 |
| Bayer | 1 | $33 |
| Johnson & Johnson | 1 | $25 |
| Amgen | 1 | $24 |
| Lantheus Medical Imaging, Inc. | 1 | $22 |
| United Therapeutics Corporation | 1 | $20 |
| Chiesi USA, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ezetimibe | 19 | $750 |
| Amlodipine Besylate | 14 | $135 |
| Atorvastatin Calcium | 15 | $38 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.